This is a preview of subscription content, log in via an institution to check access.
Notes
2018 British pounds
referable (pre-proliferative or proliferative) diabetic retinoapthy
Reference
Thomas RL, et al. Cost-effectiveness of biennial screening for diabetes related retinopathy in people with type 1 and type 2 diabetes compared to annual screening. European Journal of Health Economics : 8 May 2020. Available from: URL: https://doi.org/10.1007/s10198-020-01191-y
Rights and permissions
About this article
Cite this article
Biennial screening for retinopathy may be cost effective in diabetes. PharmacoEcon Outcomes News 853, 6 (2020). https://doi.org/10.1007/s40274-020-6801-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6801-x